TransCode Therapeutics CFO Tom Fitzgerald retires; John Tattory named interim CFO
RNAZ•CFO transition effective immediately
- TransCode Therapeutics CFO Tom Fitzgerald retired. He resigned as CFO and as a director, effective immediately.
- John Tattory named interim CFO, effective immediately. He is a managing director at Stout Risius Ross providing consulting CFO services.
- Tattory has 25+ years in finance and operations. He previously served as CFO at Cerapedics and Windtree Therapeutics.
